The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is among the leading causes of worldwide cancer‐related morbidity and mortality. Poor prognosis of HCC is attributed primarily to tumor presentation at an advanced stage when there is no effective treatment to achieve the long term survival of patients. Currently available tests such as alpha‐fetoprotein have limited accuracy as a diagnostic or prognostic biomarker for HCC. Liver biopsy provides tissue that can reveal tumor biology but it is not used routinely due to its invasiveness and risk of tumor seeding, especially in early‐stage patients. Liver biopsy is also limited in revealing comprehensive tumor biology due to intratumoral heterogeneity. There is a clear need for new biomarkers to improve HCC detection, prognostication, prediction of treatment response, and disease monitoring with treatment. Liquid biopsy could be an effective method of early detection and management of HCC. Circulating tumor cells (CTCs) are cancer cells in circulation derived from the original tumor or metastatic foci, and their measurement by liquid biopsy represents a great potential in facilitating the implementation of precision medicine in patients with HCC. CTCs can be detected by a simple peripheral blood draw and potentially show global features of tumor characteristics. Various CTC detection platforms using immunoaffinity and biophysical properties have been developed to identify and capture CTCs with high efficiency. Quantitative abundance of CTCs, as well as biological characteristics and genomic heterogeneity among the CTCs, can predict disease prognosis and response to therapy in patients with HCC. This review article will discuss the currently available technologies for CTC detection and isolation, their utility in the clinical management of HCC patients, their limitations, and future directions of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis
Wan, H., Xu, H., Gu, Y., Wang, H., Xu, W., & Zu, M. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.06.008 · Cited by 80
RetractedEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 1×
“, Bologna, Italy) uses an immunomagnetic separation system of ferrofluid beads coated with antibody to EpCAM (anti-EpCAM).(35) Microfluidic devices such as the CTC-chip (developed at the Massachusetts General Hospital, Boston, MA) are composed of antibody-coated microposts with a geometric arrangement to optimize cell…”
MethodCirculating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Self-citationGlobal Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Di Carlo, D. (2009) · Lab on a Chip · doi:10.1039/b912547g · Cited by 1,627
Isolation by Size of Epithelial Tumor Cells
Vona, G., Sabile, A., Louha, M., Sitruk, V., Romana, S., Schütze, K., Capron, F., Franco, D., Pazzagli, M., Vekemans, M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64706-2 · Cited by 1,069
Frequent EpCam protein expression in human carcinomas
Went, P. T. H., Lugli, A., Meier, S., Bundi, M., Mirlacher, M., Sauter, G., & Dirnhofer, S. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.08.026 · Cited by 819
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
Karabacak, N. M., Spuhler, P. S., Fachin, F., Lim, E. J., Pai, V., Ozkumur, E., Martel, J. M., Kojic, N., Smith, K., Chen, P.-I., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.044 · Cited by 760
Self-citationMiller, M. C., Doyle, G. V., & Terstappen, L. W. M. M. (2010) · Journal of Oncology · doi:10.1155/2010/617421 · Cited by 750
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
Sarioglu, A. F., Aceto, N., Kojic, N., Donaldson, M. C., Zeinali, M., Hamza, B., Engstrom, A., Zhu, H., Sundaresan, T. K., Miyamoto, D. T., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3404 · Cited by 709
Matrix metalloproteinases and metastasis
Kleiner, D. E., & Stetler-Stevenson, W. G. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051097 · Cited by 701
Separation of human breast cancer cells from blood by differential dielectric affinity.
Becker, F. F., Wang, X. B., Huang, Y., Pethig, R., Vykoukal, J., & Gascoyne, P. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.860 · Cited by 680
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., Heimbach, J. K., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.802 · Cited by 645
Wang, S., Liu, K., Liu, J., Yu, Z. T. ‐., Xu, X., Zhao, L., Lee, T., Lee, E. K., Reiss, J., Lee, Y., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005853 · Cited by 620
Self-citationSlanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells
Warkiani, M. E., Guan, G., Luan, K. B., Lee, W. C., Bhagat, A. A. S., Kant Chaudhuri, P., Tan, D. S.-W., Lim, W. T., Lee, S. C., Chen, P. C. Y., et al. (2014) · Lab Chip · doi:10.1039/c3lc50617g · Cited by 573
Self-citationInertial Focusing in Microfluidics
Martel, J. M., & Toner, M. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-121813-120704 · Cited by 571
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Circulating Tumor Cells and Circulating Tumor DNA
Alix-Panabières, C., Schwarzenbach, H., & Pantel, K. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062310-094219 · Cited by 485
Talasaz, A. H., Powell, A. A., Huber, D. E., Berbee, J. G., Roh, K.-H., Yu, W., Xiao, W., Davis, M. M., Pease, R. F., Mindrinos, M. N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813188106 · Cited by 480
A conduit to metastasis: circulating tumor cell biology
Micalizzi, D. S., Maheswaran, S., & Haber, D. A. (2017) · Genes & Development · doi:10.1101/gad.305805.117 · Cited by 446
Sun, Y.-F., Xu, Y., Yang, X.-R., Guo, W., Zhang, X., Qiu, S.-J., Shi, R.-Y., Hu, B., Zhou, J., & Fan, J. (2013) · Hepatology · doi:10.1002/hep.26151 · Cited by 404
Mehta, N., Heimbach, J., Harnois, D. M., Sapisochin, G., Dodge, J. L., Lee, D., Burns, J. M., Sanchez, W., Greig, P. D., Grant, D. R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5116 · Cited by 398
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Ye, Q., Ling, S., Zheng, S., & Xu, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1043-x · Cited by 379
A new device for rapid isolation by size and characterization of rare circulating tumor cells.
Desitter, I., Guerrouahen, B. S., Benali-Furet, N., Wechsler, J., Janne, P. A., Kuang, Y., Yanagita, M., Wang, L., Berkowitz, J. A., Distel, R. J., et al. (2011) · PubMed · Cited by 375
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
Marrero, J. A., Romano, P. R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C. J., Comunale, M. A., D'Amelio, A., Lok, A. S., & Block, T. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.028 · Cited by 364
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 350
Considerations in the development of circulating tumor cell technology for clinical use
Parkinson, D. R., Dracopoli, N., Petty, B. G., Compton, C., Cristofanilli, M., Deisseroth, A., Hayes, D. F., Kapke, G., Kumar, P., Lee, J. S., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-138 · Cited by 323
Qi, L.-N., Xiang, B.-D., Wu, F.-X., Ye, J.-Z., Zhong, J.-H., Wang, Y.-Y., Chen, Y.-Y., Chen, Z.-S., Ma, L., Chen, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2459 · Cited by 301
Rosenberg, R., Gertler, R., Friederichs, J., Fuehrer, K., Dahm, M., Phelps, R., Thorban, S., Nekarda, H., & Siewert, J. R. (2002) · Cytometry · doi:10.1002/cyto.10161 · Cited by 300
Hippo, Y., Watanabe, K., Watanabe, A., Midorikawa, Y., Yamamoto, S., Ihara, S., Tokita, S., Iwanari, H., Ito, Y., Nakano, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2191 · Cited by 297
Review: imaging technologies for flow cytometry
Han, Y., Gu, Y., Zhang, A. C., & Lo, Y. (2016) · Lab on a Chip · doi:10.1039/c6lc01063f · Cited by 272
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Fiala, C., & Diamandis, E. P. (2018) · BMC Medicine · doi:10.1186/s12916-018-1157-9 · Cited by 269
Schulze, K., Gasch, C., Staufer, K., Nashan, B., Lohse, A. W., Pantel, K., Riethdorf, S., & Wege, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28230 · Cited by 244
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer
Vona, G., Estepa, L., Béroud, C., Damotte, D., Capron, F., Nalpas, B., Mineur, A., Franco, D., Lacour, B., Pol, S., et al. (2004) · Hepatology · doi:10.1002/hep.20091 · Cited by 215
Satelli, A., Brownlee, Z., Mitra, A., Meng, Q. H., & Li, S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.228122 · Cited by 195
Xu, W., Cao, L., Chen, L., Li, J., Zhang, X.-F., Qian, H.-H., Kang, X.-Y., Zhang, Y., Liao, J., Shi, L.-H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0498 · Cited by 161
Sun, Y.-F., Guo, W., Xu, Y., Shi, Y.-H., Gong, Z.-J., Ji, Y., Du, M., Zhang, X., Hu, B., Huang, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1063 · Cited by 161
Schmiegel, W., Scott, R. J., Dooley, S., Lewis, W., Meldrum, C. J., Pockney, P. G., Draganic, B. D., Smith, S., Hewitt, C., Phillimore, H., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12023 · Cited by 160
Li, Y., Xu, S.-C., Li, J., Han, K.-Q., Pi, H.-F., Zheng, L., Zuo, G.-H., Huang, X.-B., Li, H.-Y., Zhao, H.-Z., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.347 · Cited by 159
Kalinich, M., Bhan, I., Kwan, T. T., Miyamoto, D. T., Javaid, S., LiCausi, J. A., Milner, J. D., Hong, X., Goyal, L., Sil, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617032114 · Cited by 158
Adams, D. L., Stefansson, S., Haudenschild, C. C., Martin, S. S., Charpentier, M. S., Chumsri, S., Cristofanilli, M., Tang, C., & Alpaugh, R. K. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22613 · Cited by 153
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Pantel, K., Hille, C., & Scher, H. I. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.287102 · Cited by 149
Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor Cells
Harouaka, R. A., Zhou, M.-D., Yeh, Y., Khan, W. J., Das, A., Liu, X., Christ, C. C., Dicker, D. T., Baney, T., Kaifi, J. T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206805 · Cited by 147
Biomarkers for Hepatocellular Carcinoma
Lou, J., Zhang, L.-F., Lv, S., Zhang, C., & Jiang, S. (2017) · Biomarkers in Cancer · doi:10.1177/1179299x16684640 · Cited by 140
Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma
Zhu, W., Guo, J., Guo, L., Jia, H., Zhu, M., Zhang, J., Loffredo, C. A., Forgues, M., Huang, H., Xing, X.-J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3363 · Cited by 139
Kelley, R. K., Magbanua, M. J. M., Butler, T. M., Collisson, E. A., Hwang, J. J., Sidiropoulos, N., Evason, K. J., McWhirter, R. M., Hameed, B., Wayne, E. M., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1195-z · Cited by 130
Ogle, L. F., Orr, J. G., Willoughby, C. E., Hutton, C., McPherson, S., Plummer, R., Boddy, A. V., Curtin, N. J., Jamieson, D., & Reeves, H. L. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.014 · Cited by 130
Circulating Tumor Cell Detection and Capture by Photoacoustic Flow Cytometry in Vivo and ex Vivo
Galanzha, E. I., & Zharov, V. P. (2013) · Cancers · doi:10.3390/cancers5041691 · Cited by 124
Seal, S. H. (1959) · Cancer · Cited by 122
Li, J., Han, X., Yu, X., Xu, Z., Yang, G., Liu, B., & Xiu, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0893-1 · Cited by 120
Guo, W., Yang, X., Sun, Y., Shen, M., Ma, X., Wu, J., Zhang, C., Zhou, Y., Xu, Y., Hu, B., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0251 · Cited by 117
Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy
Maheswaran, S., & Haber, D. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0145 · Cited by 112
Okajima, W., Komatsu, S., Ichikawa, D., Miyamae, M., Ohashi, T., Imamura, T., Kiuchi, J., Nishibeppu, K., Arita, T., Konishi, H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i31.5650 · Cited by 98
Yu, J., Xiao, W., Dong, S., Liang, H., Zhang, Z., Zhang, B., Huang, Z., Chen, Y.-F., Zhang, W., Luo, H., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4744-4 · Cited by 96
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
Siravegna, G., & Bardelli, A. (2014) · Genome biology · doi:10.1186/s13059-014-0449-4 · Cited by 90
Zhou, Y., Wang, B., Wu, J., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2526-4 · Cited by 87
Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein
Agopian, V. G., Harlander‐Locke, M. P., Markovic, D., Zarrinpar, A., Kaldas, F. M., Cheng, E. Y. L., Yersiz, H., Farmer, D. G., Hiatt, J. R., & Busuttil, R. W. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.3310 · Cited by 85
von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S., & Wege, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21208 · Cited by 85
D’Avola, D., Villacorta-Martín, C., Martins-Filho, S. N., Craig, A. J., Labgaa, I., von Felden, J., Allette, K., Bonaccorso, A., Tabrizian, P., Hartmann, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30047-y · Cited by 84
Court, C. M., Hou, S., Winograd, P., Segel, N. H., Li, Q. W., Zhu, Y., Sadeghi, S., Finn, R. S., Ganapathy, E., Song, M., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25062 · Cited by 76
Self-citationFeng, J., Zhu, R., Chang, C. H., Yu, L., Cao, F., Zhu, G., Chen, F., Xia, H., Lv, F., Zhang, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151501 · Cited by 73
Naume, B., Borgen, E., Tøssvik, S., Pavlak, N., Oates, D., & Nesland, J. M. (2004) · Cytotherapy · doi:10.1080/14653240410006086 · Cited by 70
Circulating biomarkers in hepatocellular carcinoma
Morris, K. L., Tugwood, J. D., Khoja, L., Lancashire, M., Sloane, R. A. S., Burt, D., Shenjere, P., Zhou, C., Hodgson, C., Ohtomo, T., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2508-7 · Cited by 68
Zhang, Y., Zhang, X., Zhang, J., Sun, B., Zheng, L., Li, J., Liu, S., Sui, G., & Yin, Z. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1235665 · Cited by 68
Chen, J., Cao, S., Cai, Z., Zheng, L., & Wang, Q. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170315 · Cited by 67
Ou, H., Huang, Y., Xiang, L., Chen, Z., Fang, Y., Lin, Y., Cui, Z., Sheng, Y., Li, X., & Yang, D. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5124-2 · Cited by 67
Li, J., Chen, L., Zhang, X., Zhang, Y., Liu, H., Sun, B., Zhao, L., Ge, N., Qian, H., Yang, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096185 · Cited by 66
Wang, S., Zhang, C., Wang, G., Cheng, B., Wang, Y., Chen, F., Chen, Y., Feng, M., & Xiong, B. (2016) · Theranostics · doi:10.7150/thno.15284 · Cited by 63
Alix‐Panabières, C., & Pantel, K. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1091729 · Cited by 60
Patient monitoring through liquid biopsies using circulating tumor DNA
Ulz, P., Heitzer, E., Geigl, J. B., & Speicher, M. R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30759 · Cited by 56
Li, J., Shi, L., Zhang, X., Sun, B., Yang, Y., Ge, N., Liu, H., Yang, X., Chen, L., Qian, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6104 · Cited by 55
Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer
Chen, W., Zhang, J., Huang, L., Chen, L., Zhou, Y., Tang, D., Xie, Y., Wang, H., & Huang, C. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.10.009 · Cited by 51
Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma
Cheng, Y., Luo, L., Zhang, J., Zhou, M., Tang, Y., He, G., Lu, Y., Wang, Z., & Pan, M. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-04067-y · Cited by 50
Zhang, H., Yao, M., Wu, W., Qiu, L., Sai, W., Yang, J., Zheng, W., Huang, J., & Yao, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-3678-6 · Cited by 42
Self-citationTwist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
Yin, L.-C., Luo, Z., Gao, Y.-X., Yang, L., Peng, Q., & Gao, Y. (2018) · BioMed Research International · doi:10.1155/2018/3789613 · Cited by 40
Abonnenc, M., Manaresi, N., Borgatti, M., et al. (2013) · Analytical Chemistry · doi:10.1021/ac401296m · Cited by 39
Shen, J., Wang, W., Zhu, X., & Ni, C. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2018.07.030 · Cited by 32
Molecular heterogeneity in hepatocellular carcinoma
Zhu, S., & Hoshida, Y. (2018) · Hepatic Oncology · doi:10.2217/hep-2018-0005 · Cited by 27
Biomarkers of Hepatocellular Carcinoma
Wang, H., & Wen, W. (2012) · Springer eBooks · doi:10.1007/978-3-642-28702-2_4 · Cited by 10
Cited by
Vogel, A., Meyer, T., Sapisochin, G., Salem, R., & Saborowski, A. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01200-4 · Cited by 2,427
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Piñero, F., Dirchwolf, M., & Pessôa, M. G. (2020) · Cells · doi:10.3390/cells9061370 · Cited by 498
New advances in the diagnosis and management of hepatocellular carcinoma
Yang, J. D., & Heimbach, J. K. (2020) · BMJ · doi:10.1136/bmj.m3544 · Cited by 384
Self-citationHepatocellular carcinoma: signaling pathways and therapeutic advances
Zheng, J., Wang, S., Xia, L., Sun, Z., Chan, K. M., Bernards, R., Qin, W., Chen, J., Xia, Q., & Jin, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02075-w · Cited by 341
Liver Transplantation 2023: Status Report, Current and Future Challenges
Terrault, N. A., Francoz, C., Berenguer, M., Charlton, M., & Heimbach, J. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.005 · Cited by 314
Metadata
- Authors
- Ahn, J. C., Teng, P., Chen, P., Posadas, E., Tseng, H., Lu, S. C., & Yang, J. D.
- Venue
- Hepatology
- Published
- 2021-01
- Volume
- 73
- Issue
- 1
- Pages
- 422-436
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3005408377
- Cited by
- 338
- References
- 84
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.